NCT06868810View on ClinicalTrials.gov

Comparison of 5% Nacl and 10% NaHCO3 As Contrast Agents for Lung Perfusion with EIT

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

July 14, 2024

Study Completion Date

August 26, 2024

Conditions
ARDS (Acute Respiratory Distress Syndrome)
Interventions
OTHER

Injection of hypertonic saline

Injection 10 mL of 10% NaCl through central venous catheter

OTHER

Injection of 5% NaHCO3

Injection of 5% NaHCO3 through central venous catheter

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT06868810 - Comparison of 5% Nacl and 10% NaHCO3 As Contrast Agents for Lung Perfusion with EIT | Biotech Hunter | Biotech Hunter